Related Experiment Video
Updated: Sep 10, 2025

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Diagnosis of Cardiac Amyloidosis in South Asia: Need for a Collaborative Approach from Researchers and Clinicians
Shreya Ghosh1, Dibbendhu Khanra2, Chayanika Kala3
1Department of Biological Sciences and Bioengineering; Mehta Family Centre for Engineering in Medicine, Indian Institute of Technology Kanpur, Uttar Pradesh, India; Department of Chemistry and Chemical Biology Northeastern University, Boston, Massachusetts, United States, Corresponding Author.
Insights
Accurate diagnosis of cardiac amyloidosis (CA) is now more possible due to new methods. Early CA detection is crucial for South Asian patients, especially during the COVID-19 pandemic, to improve outcomes.
Area of Science:
- Cardiology
- Medical Diagnostics
- Public Health
Background:
- Cardiac amyloidosis (CA) diagnosis has improved with recent advancements.
- Cardiovascular diseases are rising in South Asia, with many undiagnosed CA cases.
- Amyloidosis patients are susceptible to SARS-CoV-2, necessitating prompt CA diagnosis and management during the COVID-19 pandemic.
Purpose of the Study:
- To review recent diagnostic approaches for cardiac amyloidosis (CA).
- To outline adapted treatment options for CA.
- To present future initiatives for diagnosing CA in the South Asian population.
Main Methods:
- Literature review of recent diagnostic and treatment strategies for CA.
- Analysis of CA prevalence and diagnostic challenges in South Asia.
- Discussion of future diagnostic initiatives.
Main Results:
- New diagnostic tools enhance the accuracy of CA detection.
- The review covers current and future strategies for CA diagnosis and management.
- Collaborative adoption of these approaches can improve CA diagnosis in India and South Asia.
Conclusions:
- Enhanced diagnostic capabilities offer improved accuracy for cardiac amyloidosis.
- Prompt diagnosis and management of CA are vital, particularly in the context of rising cardiovascular diseases and SARS-CoV-2 susceptibility.
- Future initiatives and collaborative efforts are essential for accurate CA diagnosis in the South Asian population.
Abstract:
Recent developments in diagnostic approaches for cardiac amyloidosis (CA) have augmented the possibility of its accurate diagnosis. Rising cardiovascular diseases in South Asian countries along with many undiagnosed cases make it important for cardiologists to screen patients for CA. Besides, the increasing susceptibility of amyloidosis patients to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection needs prompt diagnosis and management of CA in the COVID-19 era. With this focus in mind, a review of recent diagnostic approaches and treatment options adapted for CA is outlined in this article. In addition, a layout of different initiatives to diagnose such patients in the future has also been depicted. These approaches, if collaboratively adopted by the researchers and clinicians, would aid in the accurate diagnosis of CA patients in the South Asian population including India.
More Related Videos
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

